Participated · Seed · Jan 2026

Allos AI applies Causal AI to model how formulation, dosing, delivery, and patient biology interact, allowing pharmaceutical partners to redesign existing complex generics and next-generation small-molecule drugs for chronic diseases. Its platform leverages real-world evidence to reduce development uncertainty, shorten clinical timelines, and create more predictable paths to regulatory approval. By turning drug reformulation into a data-driven engineering discipline, Allos aims to revive long-stalled development pathways and unlock stalled programs. The company’s transparent, or “glass-box,” models enable smaller and more interpretable clinical studies that accommodate patient heterogeneity upfront. Funding will be used to expand formulation development and data-science teams while focusing on hard-to-genericize medicines. Allos collaborates with pharmaceutical companies to modernize legacy assets and expand access to complex generics. Headquartered in Oxford, United Kingdom, the AI-native company was founded by an Oxford-trained quantum physicist, applied AI researchers, and veterans of complex generics.

Participated · Equity · Dec 2025

ICICI Prudential AMC is the asset-management subsidiary of ICICI Bank, partnering with UK-based Prudential Corporation Holdings. The firm manages a diversified suite of mutual funds and other investment products for retail and institutional clients. To prepare for a public listing, the company completed a sizeable pre-IPO round and has now set a ₹2,061–2,165 per-share price band for its upcoming ₹10,602-crore initial public offering, which will run from 12-16 December with listing expected on 19 December. The planned IPO is structured entirely as an offer-for-sale of over 4.89 crore shares by Prudential, so the company itself will not receive those proceeds. The pre-IPO equity placement valued the AMC at roughly ₹1.07 lakh crore (US $11.9 billion), highlighting strong investor demand. Post-placement, ICICI Bank increased its stake to 53 percent, while Prudential’s share will be correspondingly reduced ahead of the IPO. On listing, ICICI Prudential AMC will become the fifth asset-management firm and the fifth ICICI Group entity to trade on Indian exchanges.

Participated · Series B · May 2025

Sprinter Health operates an at-home care service that delivers preventative clinical services including blood draws, diabetes eye checks, and colorectal cancer screenings. Its core technology is a logistics and route-simulation system that optimizes schedules for clinical staff, phlebotomists cross-trained as medical assistants, and community health workers to maximize patient visits. The company says staff can serve up to 12 patients daily and that services are free to members of its health insurance partners, including Medicare and Medicaid. Sprinter has expanded rapidly, operating in 18 states (up from five in 2023) and reporting a six-fold revenue increase year-over-year. The model aims to re-engage patients who haven’t been using the health system and improve long-term health outcomes. The company has focused on tight operating systems to make at-home care unit economics sustainable. Sprinter Health is an on-demand mobile health company that dispatches fully-employed nurses and phlebotomists ('Sprinters') into patients' homes to perform lab draws, vitals checks, and COVID-19 testing. The company provides online booking, fasting reminders, ETA texts, and follow-up instructions to make in-home clinical services convenient and affordable. It partners with specialty labs, physician practices, insurers, employers, and healthcare providers to increase testing adherence and reduce the need for travel or missed work. Sprinter Health matches the appropriate licensed clinician to each medical need and uses a customized 'Sprinter Checklist' to deliver care with high quality and low error rates. The company is operating in the San Francisco Bay Area and Sacramento and plans to expand to Los Angeles and San Diego by the end of 2021, with further expansion targeted to Texas and Florida in 2022. Financially, Sprinter announced a $33 million Series A and previously raised a $4.6 million seed round; it will use the Series A proceeds to expand its last-mile in-home healthcare services into new markets.

Participated · Series A · Oct 2024

Horizon Surgical Systems develops Polaris, an assistive microsurgical robotics platform that combines state-of-the-art robotics, advanced medical imaging, and AI to extend surgeons' capabilities in eye surgery. The company positions Polaris to improve consistency, speed, and outcomes while enhancing access to care through augmented visualization and precision robotic control. Proceeds from its $30M Series A will advance Polaris development, fund progression to first-in-human studies, and support team expansion. Horizon emphasizes automated, AI-enabled robotics to push the boundaries of surgical precision in ophthalmology. The company was founded in 2021 as a spin-out from UCLA and is based in Malibu, California.

Participated · Grant · Jan 2023

Agrology builds real-time soil carbon and nitrous oxide emission monitoring technology and a climate/carbon monitoring platform for growers. Its platform combines ground-truth data and machine learning to deliver predictive warnings up to four days in advance for wildfire smoke taint risk, extreme weather, soil conditions, pest and disease emergence, and irrigation. Agrology’s Carbon Monitoring System tracks soil carbon sequestration in real time and detects carbon loss via carbon dioxide emission events. The company was founded in 2019 and is based in Alexandria, Virginia. Customers include multiple vineyards and specialty farms, and Agrology has received two National Science Foundation SBIR awards and a USDA Partnerships for Climate‑Smart Commodities grant. The company recently received a $500,000 Phase IIB grant from the National Science Foundation’s America’s Seed Fund to expand capabilities and help farmers measure and report data on climate‑smart initiatives; the award is non‑dilutive and leaves Agrology with full control of its team and intellectual property. Agrology builds a predictive agriculture platform that leverages machine learning, IoT, and extensive ground-truth data to monitor soil carbon respiration, greenhouse gases, irrigation, pests, and extreme weather. The company markets an MRV-capable system for in situ measurement and verification of CO2 flux and soil health rather than relying solely on remote sensing or indirect models. Agrology is field-testing soil carbon sequestration validation and greenhouse gas monitoring and aims to deliver the first commercially available, scalable agricultural greenhouse gas measurement and monitoring system. The company has paying customers across specialty farms and the wine industry, including Braga Fresh, The Duckhorn Portfolio, Boisset Collection, Jordan Vineyards and Winery, and others. Agrology is a Public Benefit Corporation, a winner of two NSF SBIR awards, and was founded in 2019. It maintains offices in Alexandria, Virginia and Sonoma, California. The recent USDA grant award of approximately $5M will fund expansion of real-time greenhouse gas monitoring and verification with academic and grower partners. Agrology offers a predictive agriculture platform that gathers field data with sensors and aerial inputs, then processes it with machine learning and AI to forecast conditions up to four days out. The system provides actionable insights for irrigation, pest and disease outbreaks, smoke taint, and extreme weather, and includes the company’s soil carbon respiration monitoring capability to track soil microbiome health and changes in soil carbon. Agrology positions its technology to support regenerative practices and help growers access carbon credits via soil carbon sequestration. Current customers include growers and wine-sector clients such as Braga Fresh, The Duckhorn Portfolio, Silver Oak Vineyards, Jordan Vineyards and Winery, and others. Agrology is a Public Benefit Corporation, founded in 2019, and is a two-time National Science Foundation SBIR award winner with offices in Alexandria, Virginia and Sonoma, California. The company is field-testing soil carbon sequestration validation and greenhouse-gas monitoring based on its proprietary IoT and ground-truth technology. Following its seed raise, Agrology plans to grow its team, scale operations, and expand its reach into national and international markets. Agrology builds an integrated IoT and machine-learning system that converts high-quality data from low-cost sensors into actionable predictive guidance for crop growers. Farmers install Agrology devices and use a mobile application to receive recommendations on the right amounts, locations, and timing for inputs. The company offers a hardware-and-software-as-a-service model that it says enables deployment of ten times more sensors than traditional IoT farming solutions. Agrology claims its guidance can boost crop yields by about 10% for irrigated specialty crops while reducing inputs such as water and fertilizer by roughly 10%. The startup plans to use the CIT GAP Funds investment to continue developing its sensing and machine-learning systems, improve farmer user experience, support sales and marketing, and file additional patents. Agrology is based in Alexandria, Virginia.